Note to our followers: Our nearly 13-year run of daily publication of new content on came to a close at the end of 2018. Publisher Gary Schwitzer and other contributors may post new articles periodically. But all of the 6,000+ articles we have published contain lessons to help you improve your critical thinking about health care interventions. And those will be still be alive on the site for a couple of years.
Read Original Story

Study links finger length to prostate cancer risk


0 Star


Study links finger length to prostate cancer risk

Our Review Summary

This story fails on many levels:

  • failing to make even one comment on the limitations of observational studies;
  • failing to comment on the limitations of this particular study method (a questionnaire and self-assessment);
  • allowing a researcher to claim that this approach “could be used as a simple test for prostate cancer” without challenging that comment.

And, while a brief comment was made about prostate cancer screening being “controversial,” the story never explained that the US Preventive Services Task Force concludes that there’s insufficient evidence to weigh the balance of harms and benefits in prostate cancer screening in men younger than 75.  But the story did allow a researcher to say this test could be particularly useful in men under 60.


Why This Matters

The failure to evaluate the limitations of the evidence and the failure to challenge researchers’ bold claims made this an example of stenography more than an example of journalism.


Does the story adequately quantify the benefits of the treatment/test/product/procedure?

Not Satisfactory

The numbers given were absolutely useless – “men whose index finger is longer than their ring finger were one-third less likely to develop the disease than men with the opposite pattern of finger lengths.”  There are countless questions about what this means, but the story didn’t answer them.

And, of course, the story never got around to any discussion of really meaningful potential benefits – such as, what is known about the benefits of treating prostate cancers that are picked up by screening?  Again, see the US Preventive Services Task Force conclusion that the current evidence is insufficient to assess the balance of benefits and harms of prostate cancer screening in men younger than age 75 years.”

Does the story adequately explain/quantify the harms of the intervention?

Not Satisfactory

If a story is going to let a researcher get away with saying this “could be used as a simple test for prostate cancer”- and not challenge that comment in any way, then we feel there must be balance somewhere in the story about potential harms.

The story starts to lean in the right direction when it states: “A study in the United States last year found routine prostate cancer screening there had resulted in more than one million men being diagnosed with tumors who might otherwise have suffered no ill effects from them.”

But it doesn’t specify what the harm is from this – the anxiety, the unnecessary followup testing and possible subsequent treatment carrying its own risks and costs.

Does the story seem to grasp the quality of the evidence?

Not Satisfactory

This is the fundamental problem with this story.  There isn’t one word about the limitations of such observational studies (read our primer on this topic), nor about the methods of this study.

How reliable is questioning men and showing them pictures of different finger length patterns and then asking them to identify the one most similar to their own?

Yet the story lets the researcher get away – unchallenged – with saying this “could be used as a simple test for prostate cancer.”

There is no independent expert perspective questioning this assertion or evaluting the evidence.

Does the story commit disease-mongering?

Not Satisfactory

The story does commit implicit disease-mongering by stating in the very first sentence that this is “a finding that could be used to help select those who need regular screening for the disease.”  This statement presumes that anyone would need regular screening for prostate cancer – something for which the US Preventive Services Task Force concludes that the current evidence is insufficient to assess the balance of benefits and harms of prostate cancer screening in men younger than age 75 years.”

The American Cancer Society states: “Research has not yet proven that the potential benefits of testing outweigh the harms of testing and treatment. The American Cancer Society believes that men should not be tested without learning about what we know and don’t know about the risks and possible benefits of testing and treatment.

Does the story use independent sources and identify conflicts of interest?

Not Satisfactory

There was no independent perspective in the story – something that was badly needed.

Does the story compare the new approach with existing alternatives?

Not Satisfactory

No comparison was made between this approach and other existing prostate cancer screening methods.

Does the story establish the availability of the treatment/test/product/procedure?

Not Applicable

Not applicable.  There isn’t such a test available yet.

Does the story establish the true novelty of the approach?

Not Satisfactory

The story does offer some context for this area of research when it states: “Previous studies have linked finger length to aggression, fertility, sporting ability and confidence and reaction times.”  But it fails to note that there’s been other research on the question of finger length and prostate cancer risk – in the Korean Cohort study – something mentioned in the journal article.

And the story again fails to question the evidence when it allows a researcher to state, “Our study indicates it is the hormone levels that babies are exposed to in the womb that can have an effect decades later,” when this observational study simpy can’t establish that.

Does the story appear to rely solely or largely on a news release?

Not Applicable

Not applicable.  We can’t be sure of the extent to which the story was influenced by a news release.  We do know that no independent source appeared in the story.

Total Score: 0 of 7 Satisfactory


Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.